基本信息
浏览量:2
职业迁徙
个人简介
A major interest of my research is to understand the effector immune responses that protect us against infection and cancer and how, when uncontrolled this can lead to autoimmune diseases. I am particularly interested the factors that affect the induction, of the distinct subpopulations of CD4+ T cells, termed Th1, Th2 and T regulatory (Treg) and Th17 cells, and the role of innate immune system, in particular dendritic cells, in directing T cell responses. The work has direct application to the development of new or improved vaccines and includes studies on Bordetella pertussis, Fasciola hepatica, influenza virus and hepatitis C virus. In the last number of years my group has focused on immune regulation and immune modulation by pathogens. This has been made possible through PI and Strategic research cluster (SRC) awards from Science Foundation Ireland. The aims are to examine the role of pathogen-derived molecules in modulating immune responses, with particular reference to the induction, regulation and function of T cell subtypes and the induction and control of inflammatory responses. Our hypothesis is that the study of immunomodulation by microbial pathogens is an ideal approach to understand mechanisms of protective immunity and immunoregulation in vivo and will allow the identification and characterization of novel immunomodulatory molecules with potential as therapies for immune mediated diseases. We have identified molecules capable of specifically suppressing or enhancing immune response that regulate or mediate certain human diseases. The application of this research is the development of new or improved vaccines against infectious diseases, active immunotherapeutics against cancer and anti-inflammatory therapeutics against autoimmune diseases. A recent SFI PI award on 'the role of regulatory T cell control of pathogenic and effector T cells and their manipulation as potential therapies for human disease' is focused on the interface between innate and adaptive immunity, specifically how we can manipulate dendritic cells to selectively alter the balance of regulatory (Treg) versus effector (Th1 or Th2) or pathogenic (Th17). Our aim is to design new approaches to treat autoimmunity by enhancing induction of Treg which suppress Th17 cells and to develop new infectious diseases vaccines and cancer immunotherapeutics by enhancing induction of Th1 and Th2 cells, while inhibiting Treg cells.
研究兴趣
论文共 490 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alanna M. Kelly,Karen N. McCarthy, Tracey J. Claxton, Simon R. Carlile,Eoin C. O'Brien,Emilio G. Vozza,Kingston H. G. Mills,Rachel M. McLoughlin
JCI insightno. 13 (2024)
crossref(2024)
European journal of immunologypp.e2451212-e2451212, (2024)
The journal of infectious diseases (Online University of Chicago Press)/The Journal of infectious diseases (2024)
Parasite immunologyno. 12 (2023)
crossref(2023)
Tristram A. J. Ryan,Alexander Hooftman,Aisling M. Rehill,Matt D. Johansen,Eoin C. O' Brien,Juliana E. Toller-Kawahisa,Mieszko M. Wilk,Emily A. Day,Hauke J. Weiss, Pourya Sarvari,Emilio G. Vozza,Fabian Schramm,Christian G. Peace,Alessia Zotta,Stefan Miemczyk,Christina Nalkurthi,Nicole G. Hansbro,Gavin McManus,Laura O'Doherty,Siobhan Gargan,Aideen Long,Jean Dunne,Cliona Ni Cheallaigh,Niall Conlon,Michael Carty,Padraic G. Fallon,Kingston H. G. Mills,Emma M. Creagh,James S. O' Donnell,Paul J. Hertzog,Philip M. Hansbro,Rachel M. McLoughlin,Malgorzata Wygrecka,Roger J. S. Preston,Zbigniew Zaslona,Luke A. J. O'Neill
NATURE COMMUNICATIONSno. 1 (2023)
crossref(2023)
Current Opinion in Immunology (2023): 102355
加载更多
作者统计
#Papers: 488
#Citation: 32602
H-Index: 90
G-Index: 174
Sociability: 8
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn